Onix is excited to announce that it is now part of Framework Solutions.
Click here
Skip to content
ONIX logo blue
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Contact
ONIX logo blue
Contact
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
etch weekly update image

eCTD Industry Update (13th March 2023)

March 13, 2023
/
onix

EMA

  • Newsletter: CTIS newsflash - 10 March 2023
  • Other: European Medicines Agency’s data protection notice for the European Union (EU) Metadata Catalogue
  • Other: Orphan medicines figures 2000-2022 (updated)
  • Report: Annual report on the use of the special contribution for orphan medicinal products - 2022
  • Report: Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 January 2023, edition 10)

Health Canada 

  • Health Canada changes filing requirements for product monographs: Notice[2023-03-10]
  • Notice to stakeholders – Clarification of requirements under the Food and Drug Regulations when conducting clinical trials with cannabis[2023-03-09]
  • Consultation period extended until April 26, 2023 for proposed agile regulations and guidance for licensing drugs and medical devices[2023-03-06]

 

PreveCTD Industry Update (6th March 2023)
eCTD Industry Update (17th March 2023)Next
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Twitter Linkedin

© Copyright 2023

ONIX Life Sciences Ltd, 59-60 Thames Street, Windsor, Berkshire, SL4 1TX.

ONIX Life Sciences Inc, 500 Delaware Ave, Ste 1 #1960, Wilmington, DE 19899, USA

ONIX Life Sciences Ltd, Salarpuria Sanctity, Kasavanahalli, Sarjapur Road, Bangalore 560035 India

+44 (0) 1753 257 904 | info@onixls.com | www.onixls.com

Privacy Policy